The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Regulatory News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.00
Bid: 17.50
Ask: 18.50
Change: 0.00 (0.00%)
Spread: 1.00 (5.714%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 18.00
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

11 Sep 2017 12:00

RNS Number : 3593Q
OptiBiotix Health PLC
11 September 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Optibiotix Health plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

x

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

David Evans

City and country of registered office (if applicable)

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

08/09/2017

6. Date on which issuer notified (DD/MM/YYYY):

09/09/2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

2.8%

2,198,517

Position of previous notification (if

applicable)

3.4%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary GB00BP0RTP38

2,198,517

2.79%

SUBTOTAL 8. A

2,198,517

2.79%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

x

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

Kincardine Fife

Date of completion

10th September 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLGGUCABUPMURG
Date   Source Headline
5th Jun 20152:32 pmRNSExercise of Warrants and Issue of Equity
3rd Jun 20155:50 pmRNSHolding(s) in Company
2nd Jun 20157:00 amRNSContract with multinational consumer goods company
29th May 20157:00 amRNSFinal Results
28th May 20157:00 amRNSNew patent filings
26th May 20157:01 amRNSExercise of Warrants and Issue of Equity
15th May 20153:22 pmRNSHolding(s) in Company
13th May 20157:00 amRNSNotice of Results
21st Apr 20152:24 pmRNSExercise of Warrants and Issue of Equity
17th Apr 20157:00 amRNSResearch Update
14th Apr 20157:00 amRNSUK Investor Show attendance
10th Apr 20154:35 pmRNSPrice Monitoring Extension
8th Apr 20155:26 pmRNSHolding(s) in Company
31st Mar 20155:32 pmRNSGrant of Options
25th Mar 201512:54 pmRNSHolding(s) in Company
20th Mar 201510:32 amRNSExercise of Warrants and Issue of Equity
10th Mar 20157:02 amRNSContract signed with NIZO Food Research
23rd Feb 20157:00 amRNSInvestor Teach In
18th Feb 20157:00 amRNSBoard Appointment
4th Feb 20154:03 pmRNSHolding(s) in Company
21st Jan 20157:00 amRNSJoint venture with Nizo Food Research
20th Jan 20153:23 pmRNSExercise of Warrants and Issue of Equity
15th Jan 20157:00 amRNSAdditions to Scientific Advisory Group
9th Jan 20152:24 pmRNSExercise of Warrants and Issue of Equity
15th Dec 20147:00 amRNSCompletion of ethics approval & study recruitment
10th Dec 20147:00 amRNSChange of Adviser
2nd Dec 20147:00 amRNSSuccessful completion of pre-clinical studies
28th Nov 20142:34 pmRNSHolding(s) in Company
28th Nov 20147:00 amRNSProduct showcased at Health Ingredients Europe
27th Nov 20144:57 pmRNSExercise of Warrants
25th Nov 20147:00 amRNSAppointment of Non-Executive Director
18th Nov 20147:00 amRNSAppointment of Head of Research
14th Nov 20142:46 pmRNSIssue of Equity
11th Nov 20147:00 amRNSContract Signed to Start Clinical Studies
28th Oct 20147:00 amRNSIncorporation of Weight Management Formulation
20th Oct 20147:00 amRNSScientific Advisory Group
1st Oct 20144:08 pmRNSExercise of Warrants
17th Sep 20147:00 amRNSContract signed with Nizo Food Research
5th Aug 20147:00 amRNSFirst day of dealings on AIM
4th Aug 20143:27 pmRNSChange of Name
4th Aug 201411:19 amRNSResult of General Meeting
18th Jul 20144:08 pmRNSExercise of Warrants and Issue of Equity
18th Jul 20147:30 amRNSSchedule 1 - Ducat Ventures plc
18th Jul 20147:30 amRNSRestoration - Ducat Ventures plc
18th Jul 20147:00 amRNSPublication of Admission Document & Restoration...
18th Jul 20147:00 amRNSHalf Yearly Results
9th May 201411:05 amRNSTemporary Suspension
9th May 201411:03 amRNSSuspension - Ducat Ventures Plc
24th Feb 20142:54 pmRNSResult of AGM
20th Feb 20149:10 amRNSResult of Open Offer and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.